Sheila Denton
General Counsel bei INCYTE CORPORATION
Vermögen: 2 Mio $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Sheila Denton
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 24 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Sheila Denton
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer President Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | President Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Graduate Degree Corporate Officer/Principal | |
| CRISPR THERAPEUTICS AG | Biotechnology | Director/Board Member Director/Board Member | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Investor Relations Contact | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Public Communications Contact | |
| RUBIUS THERAPEUTICS | Biotechnology | Chief Executive Officer Director/Board Member | |
| CELGENE | Biotechnology | Director of Finance/CFO Compliance Officer | |
| GENOMIC HEALTH, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
| EXACT SCIENCES CORPORATION | Medical Specialties | Director/Board Member | |
| PARATEK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Biotechnology | Chairman | |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Medical/Nursing Services | Chairman | |
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Columbia Business School | College/University | Masters Business Admin | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Babson College | College/University | Undergraduate Degree | |
Stromedix, Inc.
 Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| PEPSICO, INC. | Food: Specialty/Candy | Corporate Officer/Principal | |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | President | |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Chairman | |
Bunge Ltd.
 Bunge Ltd. Agricultural Commodities/MillingProcess Industries Bunge Global SA operates as a holding company. engages in the supply and transportation of agricultural commodities. It operates through the following segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The Agribusiness segment is involved in the purchase, storage, transportation, processing, and sale of agricultural commodities and commodity products. The Refined and Specialty Oils segment engages in the processing, production, and marketing of products derived from vegetable oils. The Milling segment consists of the processing, production, and marketing of products derived primarily from wheat and corn. The Sugar and Bioenergy segment includes the manufacture and marketing of sugar and ethanol derived from sugarcane, as well as energy derived from the sugar and ethanol production process. The company was founded by Johann Peter Gottlieb Bunge in 1818 and is headquartered in St. Louis, MO. | Agricultural Commodities/Milling | Director of Finance/CFO | |
Delaware BioScience Association
 Delaware BioScience Association Miscellaneous Commercial ServicesCommercial Services Delaware BioScience Association promotes Delaware's bioscience industry. It facilitates growth of the life science industry, advancements in research as well as supporting education initiatives in Delaware and the surrounding region. The company was founded in 2006 and is headquartered in Newark, DE. | Miscellaneous Commercial Services | Director/Board Member | |
| Philipps University of Marburg | College/University | Doctorate Degree | |
EMD Pharmaceuticals, Inc.
 EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Lexigen Pharmaceuticals Corp.
 Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Basel Institute for Immunology | College/University | Corporate Officer/Principal | |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Medical Specialties | Director of Finance/CFO | |
ORBIS International, Inc.
 ORBIS International, Inc. Hospital/Nursing ManagementHealth Services ORBIS International, Inc. prevents and treats blindness by providing eye care to transform lives. It offers tools, training and technology necessary for local partners to develop eye care services. The company was founded in 1982 by David Paton and is headquartered in New York, NY. | Hospital/Nursing Management | Director/Board Member | |
| McCallum Graduate School of Business | College/University | Masters Business Admin | |
| ALCON INC. | Medical Specialties | Director of Finance/CFO | |
| DICK'S SPORTING GOODS, INC. | Specialty Stores | Director/Board Member | |
| PERRIGO COMPANY PLC | Pharmaceuticals: Major | Director/Board Member | |
| NESTLÉ S.A. | Food: Major Diversified | Treasurer |
Statistik
International
| Vereinigte Staaten | 40 |
| Schweiz | 8 |
| Deutschland | 3 |
| Irland | 2 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 8 |
| Commercial Services | 4 |
| Finance | 3 |
| Health Services | 3 |
Operativ
| Director/Board Member | 94 |
| Corporate Officer/Principal | 58 |
| Independent Dir/Board Member | 44 |
| President | 19 |
| Undergraduate Degree | 17 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Pablo Cagnoni | 24 |
| Jean-Jacques Bienaimé | 22 |
| Julian Baker | 20 |
| Jacqualyn Fouse | 18 |
| Otis Brawley | 15 |
| Paul Clancy | 14 |
| Susanne Antonie Schaffert | 13 |
| Katherine High | 12 |
| Herve Hoppenot | 11 |
| Barry Flannelly | 10 |
| Steven Stein | 10 |
| Edmund Harrigan | 10 |
| Vijay Iyengar | 9 |
| Paula Swain | 8 |
| Christiana Stamoulis | 8 |
- Börse
- Insiders
- Sheila Denton
- Unternehmensverbindungen
